Eli Lilly and Company (LLY)

Eli Lilly Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	34,124	28,541	28,318	24,540	22,320
Revenue Growth (YoY)	19.56%	0.79%	15.40%	9.95%	3.84%
Cost of Revenue	7,082	6,630	7,313	5,483	4,721
Gross Profit	27,042	21,912	21,006	19,057	17,598
Selling, General & Admin	7,403	6,440	6,432	6,121	6,214
Research & Development	9,313	7,191	6,931	5,976	5,595
Other Operating Expenses	3,771	1,474	1,488	-270.9	523.6
Operating Expenses	20,487	15,105	14,850	11,827	12,332
Operating Income	6,555	6,806	6,156	7,230	5,266
Other Expense / Income	-	-	-	-	-3,680.5
Pretax Income	6,555	6,806	6,156	7,230	8,946
Income Tax	1,314	561.6	573.8	1,036	628
Net Income	5,240	6,245	5,582	6,194	8,318
Net Income Growth	-16.08%	11.88%	-9.88%	-25.54%	157.38%
Shares Outstanding (Basic)	900	902	907	908	931
Shares Outstanding (Diluted)	903	905	912	913	936
Shares Change	-0.15%	-0.77%	-0.09%	-2.48%	-9.48%
EPS (Basic)	5.82	6.93	6.15	6.82	8.93
EPS (Diluted)	5.80	6.90	6.12	6.79	8.89
EPS Growth	-15.94%	12.75%	-9.87%	-23.62%	184.03%
Free Cash Flow	792.5	5,731	6,056	5,112	3,803
Free Cash Flow Per Share	0.88	6.36	6.68	5.63	4.08
Dividend Per Share	4.520	3.920	3.400	2.960	2.580
Dividend Growth	15.31%	15.29%	14.86%	14.73%	14.62%
Gross Margin	79.25%	76.77%	74.18%	77.66%	78.85%
Operating Margin	19.21%	23.85%	21.74%	29.46%	23.59%
Profit Margin	15.36%	21.88%	19.71%	25.24%	37.27%
Free Cash Flow Margin	2.32%	20.08%	21.39%	20.83%	17.04%
Effective Tax Rate	20.05%	8.25%	9.32%	14.33%	7.02%
EBITDA	8,082	8,329	7,703	8,554	10,179
EBITDA Margin	23.68%	29.18%	27.20%	34.86%	45.61%
Depreciation & Amortization	1,527	1,523	1,548	1,324	1,233
EBIT	6,555	6,806	6,156	7,230	8,946
EBIT Margin	19.21%	23.85%	21.74%	29.46%	40.08%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).